Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis

Human Pathology

Volumn 29, Issue 2, 1998, Pages 175-180

  Terada, Tadashi ^b   Nakanuma, Yasuni ^b   Sirica, Alphonse E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Biliary ducts; Cholangiocarcinoma; Fetal liver; Hepatolithiasis; Immunohistochemistry; MET

Indexed keywords

GROWTH FACTOR RECEPTOR; SCATTER FACTOR;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT STONE; CANCER RISK; CELL PROLIFERATION; CONTROLLED STUDY; FETUS; FETUS LIVER; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC BILE DUCT; LIVER DEVELOPMENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

EID: 0031912249     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90229-5     Document Type: Article

References (39)

1. Vigna E, Naldini L, Tamagnone L, et al: Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-met proto-oncogene. Cell Mol Biol 40:597-604, 1994
2. Bottaro DP, Rubin JS, Faletto DL, et al: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802-804, 1991
3. Prat M, Narsimhan RP, Crepaldi T, et al: The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 49:323-328, 1991
4. Ebert M, Yokoyama M, Friess H, et al: Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 54:5775-5778, 1994
5. Furukawa T, Duguid WP, Kobari M, et al: Hepatocyte growth factor and met receptor expression in human pancreatic carcinogenesis. Am J Pathol 147:889-895, 1995
6. Suzuki K, Hayashi N, Yamada Y, et al: Expression of the c-met proto-oncogene in human hepatocellular carcinoma. Hepatology 20:1231-1236, 1994
7. Grigioni WF, Fiorentino M, D'Errico A, et al: Overexpression of c-met proto-oncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions. Hepatology 21:1543-1546, 1995
8. D'Errico A, Fiorentino M, Ponzetto A, et al: Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: Its specific receptor c-met does. Hepatology 24:60-64, 1996
9. Nakanuma Y, Terada T, Tanaka Y, et al: Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma. Virchows Arch (Pathol Anat) 406:45-58, 1985
10. Terada T, Nakanuma Y, Ohta T, et al: Histological features and interphase nucleolar organizer regions in hyperplastic, dysplastic and neoplastic epithelium of intrahepatic bile ducts in hepatolithiasis. Histopathology 21:233-240, 1992
11. Joplin R, Hishida T, Tsubouchi H, et al: Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J Clin Invest 90:1284-1289, 1992
12. Matsumoto K, Fujii H, Michalopoulos G, et al: Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: Interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology 20:376-382, 1994
13. Shimura H, Date K, Matsumoto K, et al: Induction of invasive growth in a gallbladder cancer cell line by hepatocyte growth factor in vitro. Jpn J Cancer Res 86:662-669, 1995
14. Matsumoto K, Date K, Shimura H, et al: Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn J Cancer Res 87:702-710, 1996
15. Hsu S-M, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
16. Terada T, Nakanuma Y: Immunohistochemical demonstration of pancreatic α-amylase and trypsin in intrahepatic bile ducts and peribiliary glands. Hepatology 14:1129-1135, 1991
17. Terada T, Nakanuma Y, Ohta G: Glandular elements around the intrahepatic bile ducts in man: Their morphology and distribution in normal livers. Liver 7:1-8, 1987
18. Van Eyken P, Sciot R, Callea F, et al: The development of the intrahepatic bile ducts in man: A keratin-immunohistochemical study. Hepatology 8:1586-1595, 1988
19. Terada T, Nakanuma Y: Expression of pancreatic enzymes (a-amylase, trypsinogen and lipase) during human liver development and maturation. Gastroenterology 108:1236-1245, 1995
20. Su W-C, Chan K-K, Lin X-Z, et al: A clinical study of 130 patients with biliary tract cancers and periampullary tumors. Oncology 53:488-493, 1996
21. Gonzatti-Haces M, Seth A, Park M, et al: Characterization of the TPR-MET oncogene P65 and MET proto-oncogene P140 proteintyrosine kinases. Proc Natl Acad Sci U S A 85:21-25, 1988
22. Rong S, Bodescot M, Blair D, et al: Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 12:5152-5158, 1992
23. Humphrey PA, Zhu X, Zarnegar R, et al: Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol 147:386-396, 1995
24. Takanami I, Tanana F, Hashizume T, et al: Hepatocyte growth factor and c-met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: An evaluation of their expression as prognostic markers. Lab Invest 53:392-397, 1996
25. Tuck AB, Park M, Sterns EE, et al: Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol 148:225-232, 1996
26. Ruco LP, Ranalli T, Marzullo A, et al: Expression of Met protein in thyroid tumours. J Pathol 180:266-270, 1996
27. Tsarfaty I, Resau JH, Rulong S, et al: The met protooncogene receptor and lumen formation. Science 257:1258-1261, 1992
28. Crepaldi T, Prat M, Giordano S, et al: Generation of a truncated hepatocyte growth factor receptor in the endoplasmic reticulum. J Biol Chem 269:1750-1755, 1994
29. Boccaccio C, Gaudino G, Gambarotta G, et al: Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. J Biol Chem 269:12846-12851, 1994
30. deJuàn C, Sânchez A, Nakamura T, et al: Hepatocyte growth factor up-regulates met expression in rat fetal hepatocytes in primary culture. Biochem Biophys Res Commun 204:1364-1370, 1994
31. YoshinagaY, Matsuno Y, Fujita S, et al: Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn J Cancer Res 84:1150-1158, 1993
32. Sirica AE: Biliary proliferation and adaptation in furaninduced rat liver injury and carcinogenesis. Toxicol Pathol 24:90-99, 1996
33. Sirica AE, Gainey TW, Harrell M, et al: Cholangiocarcinogenesis and biliary adaptation responses in hepatic injury, in Sirica AE, Longnecker DS (eds): Biliary and Pancreatic Ductal Epithelia: Pathobiology and Pathophysiology. New York, NY, Marcel Dekker, 1997, pp 229-290
34. Selden C, Jones M, Wade D, et al: Hepatotropin mRNA expression in human foetal liver development and in liver regeneration. FEBS Lett 270:81-84, 1990
35. Wang Y, Selden C, Farnaud S, et al: Hepatocyte growth factor (HGF/SF) is expressed in human epithelial cells during embryonic development: Studies by in situ hybridization and Northern blot analysis. J Anat 185:543-551, 1994
36. DiRenzo MF, Olivero M, Ferro S, et al: Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7:2549-2553, 1992
37. Wolf H, Zarnegar R, Michalopoulos GK: Localization of hepatocyte growth factor in human and rat tissues: An immunohistochemical study. Hepatology 14:488-494, 1991
38. Di Renzo MF, Olivero M, Giacomini A, et al: Overexpression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1:147-154, 1995
39. Voravud N, Foster CS, Gilbertson JA, et al: Oncogene expression in cholangiocarcinoma and in normal hepatic development. HUM PATHOL 20:1163-1168, 1989